BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36696426)

  • 1. Analysis of regulatory sequences in exosomal DNA of NANOGP8.
    Vaidya M; Smith J; Field M; Sugaya K
    PLoS One; 2023; 18(1):e0280959. PubMed ID: 36696426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sequences of exosomal NANOG DNA as a potential diagnostic cancer marker.
    Vaidya M; Bacchus M; Sugaya K
    PLoS One; 2018; 13(5):e0197782. PubMed ID: 29787607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    Vaidya M; Sugaya K
    PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fli-1 promotes proliferation and upregulates NANOGP8 expression in T-lymphocyte leukemia cells.
    Park SW; Do HJ; Choi W; Kim JH
    Biochimie; 2020 Jan; 168():1-9. PubMed ID: 31626853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NANOGP8: evolution of a human-specific retro-oncogene.
    Fairbanks DJ; Fairbanks AD; Ogden TH; Parker GJ; Maughan PJ
    G3 (Bethesda); 2012 Nov; 2(11):1447-57. PubMed ID: 23173096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Restriction Endonuclease-Based Assay to Distinguish NANOGP8 Retrogene from Parental NANOG.
    Thakur H; Mattoo AR
    Methods Mol Biol; 2021; 2324():255-262. PubMed ID: 34165720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma.
    Zhang Z; Yin J; Lu C; Wei Y; Zeng A; You Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):166. PubMed ID: 30992025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.
    Ambady S; Malcuit C; Kashpur O; Kole D; Holmes WF; Hedblom E; Page RL; Dominko T
    Int J Dev Biol; 2010; 54(11-12):1743-54. PubMed ID: 21136380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal transfer of miR‑25‑3p promotes the proliferation and temozolomide resistance of glioblastoma cells by targeting FBXW7.
    Wang J; Li T; Wang B
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cells activate the cancer stem cell-associated NANOGP8 pathway in colorectal cancer cells in a paracrine fashion.
    Wang R; Bhattacharya R; Ye X; Fan F; Boulbes DR; Xia L; Ellis LM
    Mol Oncol; 2017 Aug; 11(8):1023-1034. PubMed ID: 28453235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOG modulates stemness in human colorectal cancer.
    Zhang J; Espinoza LA; Kinders RJ; Lawrence SM; Pfister TD; Zhou M; Veenstra TD; Thorgeirsson SS; Jessup JM
    Oncogene; 2013 Sep; 32(37):4397-405. PubMed ID: 23085761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NANOGP8 is a retrogene expressed in cancers.
    Zhang J; Wang X; Li M; Han J; Chen B; Wang B; Dai J
    FEBS J; 2006 Apr; 273(8):1723-30. PubMed ID: 16623708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated 5'flanking region of NANOGP8 in a self-renewal environment is associated with increased sphere formation and tumor growth of prostate cancer cells.
    Zhang K; Fowler M; Glass J; Yin H
    Prostate; 2014 Apr; 74(4):381-94. PubMed ID: 24318967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer.
    Palla AR; Piazzolla D; Abad M; Li H; Dominguez O; Schonthaler HB; Wagner EF; Serrano M
    Oncogene; 2014 May; 33(19):2513-9. PubMed ID: 23752184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation.
    Mikulenkova E; Neradil J; Vymazal O; Skoda J; Veselska R
    Cells; 2020 Mar; 9(3):. PubMed ID: 32168958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.
    Liu B; Badeaux MD; Choy G; Chandra D; Shen I; Jeter CR; Rycaj K; Lee CF; Person MD; Liu C; Chen Y; Shen J; Jung SY; Qin J; Tang DG
    PLoS One; 2014; 9(3):e90615. PubMed ID: 24598770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma.
    Zeng A; Wei Z; Yan W; Yin J; Huang X; Zhou X; Li R; Shen F; Wu W; Wang X; You Y
    Cancer Lett; 2018 Nov; 436():10-21. PubMed ID: 30102952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo functional studies of tumor-specific retrogene NanogP8 in transgenic animals.
    Badeaux MA; Jeter CR; Gong S; Liu B; Suraneni MV; Rundhaug J; Fischer SM; Yang T; Kusewitt D; Tang DG
    Cell Cycle; 2013 Aug; 12(15):2395-408. PubMed ID: 23839044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.